C19H22FN3O3
359.4 g/mol
Aktif Farmasötik İngredientTehlike
Enrofloxacin
CAS93106-60-6
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Heterosiklik
Birincil Kullanım
Farmasötik ham madde
Enrofloxacin is a synthetic antibacterial compound used as an active pharmaceutical ingredient. It is characterized by a quinolone core structure with fluorine and piperazine substituents, contributing to its physicochemical properties such as moderate lipophilicity and limited aqueous solubility.
manufacturing of veterinary pharmaceutical formulationsraw material for solubility-enhanced salt forms
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 93106-60-6
İlgili Bileşikler
GüçlüAynı ana yapı
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1)
CAS112732-17-9
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.73
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS864443-44-7
antibacterial impurity standard
ReferansAynı kategori
Ciprofloxacin Hydrochloride Anhydrous
CAS93107-08-5
active pharmaceutical ingredient
ReferansAynı kategori
2-(4-methanesulfonylphenyl)oxirane
CAS93114-06-8
Active pharmaceutical ingredient intermediate
ReferansAynı kategori
TACALCITOL MONOHYDRATE
CAS93129-94-3
active pharmaceutical ingredient
ReferansAynı kategori
Levobetaxolol
CAS93221-48-8
beta-adrenergic receptor antagonist
Referanssame scaffold
Desfluorociprofloxacin
CAS93107-11-0
pharmaceutical impurity reference standard
Referanssame scaffold
Gatifloxacin sesquihydrate
CAS180200-66-2
fluoroquinolone antibiotic active pharmaceutical ingredient
Güvenlik Referansı
Tehlike
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Tanımlayıcılar
IUPAC Adı
1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChIKey
SPFYMRJSYKOXGV-UHFFFAOYSA-N
SMILES
CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
Eş Anlamlılar (79)
- CFPQ
- ERFX
- Enrofloxacin (USAN/INN)
- Enrofloxacin (USP/INN)
- Enrofloxacin for system suitability, European Pharmacopoeia (EP)
- Enrofloxacin, European Pharmacopoeia (EP)
- Enrofloxacin, United States Pharmacopeia (USP)
- BAY VP 2674
- BAY Vp 2674;PD160788
- Baytril
- Baytril (TN)
- Baytril (veterinary)
- Baytril Soft Chewable Tablets
- ENROFLOXACIN 100
- ENROFLOXACIN [MART.]
- EnroMed
- EnroMed 100
- EnroPro 100
- EnroPro 22.7
- Enroflox
- Enroflox 100
- Enroflox Chewable Tablets
- Enroflox Injection for Dogs
- Enrofloxacin
- Enrofloxacin (Standard)
- Enrofloxacin CRS
- Enrofloxacin Flavored
- Enrofloxacin Flavored Tablets
- Enrofloxacin HCl
- Enrofloxacin base
- Enrofloxacin, >=98.0% (HPLC)
- Enrofloxacin, VETRANAL(TM)
- Enrofloxacine
- Enrofloxacine [French]
- Enrofloxacino
- Enrofloxacino [Spanish]
- Enrofloxacinum
- Enrofloxacinum [Latin]
- Enroquin
- Enroquin Flavored
- Enrosite
- Enrosite Flavored
- Enroxil
- Fluroxin
- Fluroxin Flavored
- Fluroxin for Dogs
- N-Ethylciprofloxacin
- Quellaxcin
- SolutionKits
- SolutionKits Enrofloxacin
- Tenotryl
- Zobuxa
- endrofloxicin